Enovix Corporation Reports 85% Revenue Growth to $7.99 Million, Despite Increased Net Loss

Enovix Corporation reported significant financial developments in its latest 10-Q filing for the fiscal quarter ending September 28, 2025. The company generated revenue of $7.99 million, marking an 85% increase from $4.32 million in the same quarter of the previous year. This growth was primarily driven by heightened demand for its lithium-ion batteries, particularly from South Korean defense contractors. For the fiscal year-to-date, revenue reached $20.56 million, up 54% from $13.36 million in the prior year, with a notable contribution of $12.3 million from a single South Korean defense contractor.

Despite the revenue increase, Enovix reported a net loss of $53.77 million for the quarter, compared to a loss of $22.64 million in the prior year, reflecting a 138% increase in losses. The company's operating expenses remained relatively stable, totaling $48.37 million, a slight decrease from $48.63 million in the previous year. Research and development expenses rose to $28.18 million, up 16% year-over-year, while selling, general, and administrative expenses decreased by 3% to $20.19 million. The increase in losses was largely attributed to a significant rise in interest expenses, which surged to $11.77 million from $1.72 million, primarily due to a one-time charge related to warrants issued to holders of the 2028 Convertible Senior Notes.

Strategically, Enovix has made notable advancements, including the acquisition of battery cell manufacturing assets from SolarEdge Technologies for $10 million, which is expected to enhance its production capabilities in South Korea. The company also launched its AI-1 smartphone battery platform, which has been validated for its high energy density. Enovix has expanded its customer base, delivering over 1,000 AI-1 battery packs to its lead customer and engaging with multiple original equipment manufacturers in the smart eyewear sector.

Operationally, Enovix has seen improvements in its manufacturing processes, particularly at its facility in Malaysia, where it has increased production capacity. The company reported that it shipped over $20 million worth of products to customers in the defense sector during the fiscal year-to-date. As of September 28, 2025, Enovix had cash and cash equivalents totaling $335.5 million, alongside short-term investments of $223.3 million, providing a solid financial foundation for future growth initiatives. Looking ahead, the company anticipates continued investment in its manufacturing capabilities and product development, while also managing its operating expenses to align with revenue growth.